Theralase Technologies Inc (TLTFF)

[was CUIN2]

Theralase Affiliated Researchers to Present at International Conference

Accesswire AccesswireApril 12, 2017
TORONTO, ON / ACCESSWIRE / April 12, 2017 / Theralase Technologies Inc. ("Theralase®" or the "Company") (TLT.V) (OTC PINK: TLTFF), a leading biotech company focused on the commercialization of medical lasers to eliminate pain and the development of Photo Dynamic Compounds ("PDCs") to destroy cancer, announced today that three Theralase affiliated researchers have been invited to present their latest research at the 16th International Photodynamic Association ("IPA") World Congress.
The 16th IPA Congress brings together researchers and clinicians working in the fields of Photo Dynamic Therapy ("PDT") and Photo Diagnosis ("PD") to foster scientific development and contribute to the widespread use of the best clinical practices. IPA Congresses are the privileged forums to present new advances in PDT and photomedicine. A variety of research and clinical advances will be addressed in more than 130 invited lectures and contributed talks, by an impressive list of lecturers.

http://finance.yahoo.com/news/theralase-affiliated-researchers-present-international-150000709.html;_ylc=X1MDMTE5Nzc4NDE4NQRfZXgDMQRfeXJpZAMzZXUwM3V0Y2VzZ29kBGcDZFhWcFpEeHVjejR6Tm1KaE1tVTFaUzFoTkRSbExUTTJNR1F0T1RCa1l5MDVPR1EwTmpCbVlUa3lZV004Wm1sbGJHUStkR3gwTG5ZPQRsYW5nA2VuLVVTBG9yaWdfbGFuZwNlbgRvcmlnX3JlZ2lvbgNVUwRwb3MDMARyZWdpb24DVVMEc3ltYm9sA1RMVC5W?.tsrc=applewf